CTOs on the Move

Athos

www.liveathos.com

 
Athos is a venture-backed startup developing a revolutionary product for the fitness and athletic market. We are creating next generation wearable technology that gives you real insight into how your body works as you move and combining it with a beautiful user experience that will fit right into your existing routine. Our goal is to empower you to make more informed decisions while pursuing a healthy, active lifestyle.
  • Number of Employees: 5K-10K
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Athos raised $35M on 11/18/2015

Similar Companies

Sarasota Memorial Hospital

Sarasota Memorial Hospital is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Sarasota, FL. To find more information about Sarasota Memorial Hospital, please visit www.smh.com

NationsBenefits

NationsBenefits is a leading supplemental benefits company that guarantees cost savings and long-term health outcomes to managed care organizations and their members.

BPR Health International

BPR Health International is a Moraga, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Breathe California

Breathe California is a Daly City, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Stilla Technologies

Stilla Technologies is a leading global biotechnology company that focuses on accelerating development of next-generation genetic testing by providing researchers and clinicians with a flexible Digital PCR solution for high-resolution genetic analysis and assay development. Stilla`s next-generation Multiplex Crystal Digital PCR™ technology employs cutting-edge microfluidic innovations and integrates the entire dPCR process on a single chip. The naica® system is highly sensitive, fast, and features an easy workflow, higher levels of multiplexing, and intuitive software. Stilla developed the world`s first 6-color Digital PCR Platform, providing High Multiplexing and Sensitivity for Advancing Cancer & Liquid Biopsy Studies, Cell & Gene Therapies, Infectious Disease & COVID-19 Research, and Wastewater and Environmental Testing and many more applications. Stilla aims to make Digital PCR a lab commodity in all life sciences areas including research, therapeutics, and the omics.